References
- Bernabeua E, Helguera G, Legaspia M, Gonzalez L. (2014). Paclitaxel-loaded PCL–TPGS nanoparticles: in vitro and in vivo performance compared with Abraxane®. Colloids Surf B Biointerfaces 113:43–5
- Du Y-Z, Wang L, Yuan H, Hu F-Q. (2011). Linoleic acid-grafted chitosan oligosaccharide micelles for intracellular drug delivery and reverse drug resistance of tumor cells. Int J Biol Macromol 48:215–22
- Emami J, Rezazadeh M, Rostami M, et al. (2014). Co-delivery of paclitaxel and α-tocopherol succinate by novel chitosan-based polymeric micelles for improving micellar stability and efficacious combination therapy. Drug Dev Ind Pharm 1–11. Early online, DOI: 10.3109/03639045.2014.935390
- Emami J, Rezazadeh M, Varshosaz J, et al. (2012). Formulation of LDL targeted nanostructured lipid carriers loaded with paclitaxel: a detailed study of preparation, freeze drying condition, and in vitro cytotoxicity. J Nanomaterials. doi:10.1155/2012/358782
- Fetterly GJ, Straubinger RM. (2003). Pharmacokinetics of paclitaxel-containing liposomes in rats. AAPS Pharm Sci 5:123–9
- Hami Z, Aminib M, Ghazi-Khansaric M, et al. (2014). Synthesis and in vitro evaluation of a pH-sensitive PLA–PEG–folatebased polymeric micelle for controlled delivery of docetaxel. Colloids Surf B Biointerfaces 116:309–17
- Hawkins MJ, Soon-Shiong P, Desai N. Protein nanoparticles as drug carriers in clinical medicine. Adv Drug Deliv Rev 2008:60:876–85
- He L, Wang G, Zhang Q. (2003). An alternative paclitaxel microemulsion formulatiom: hypersensitivity evaluation and pharmacokinetic profiles. Int J Pharm 250:45–50
- Hong G, Yuan R, Liang B, et al. (2008). Folate-functionalized polymeric micelle as hepatic carcinoma-targeted, MRI-ultrasensitive delivery system of antitumor drugs. Biomed Microdevices 5:693–700
- Hu FQ, Meng P, Dai YQ, et al. (2008). PEGylated chitosan-based polymer micelle as an intracellular delivery carrier for anti-tumor targeting therapy. Eur J Pharm Biopharm 70:749–57
- Kim SC, Kim DW, Shim YH, et al. (2001). In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy. J Control Release 72:191–202
- Liu J, Li H, Chen D, et al. (2011). In vivo evaluation of novel chitosan graft polymeric micelles for delivery of paclitaxel. Drug Deliv 18:181–9
- Liu J, Zeng F, Allen C. (2007). In vivo fate of unimers and micelles of a poly(ethylene glycol)-block-poly (caprolactone) copolymer in mice following intravenous administration. Eur J Pharm Biopharm 65:309–19
- Nam J-P, Park S-C, Kim T-H, Jang J-Y, Choi Ch, Jang M-K, Nah J-W. (2013). Encapsulation of paclitaxelinto lauric acid-o-carboxymethyl chitosan-transferin micelles for hydrophobic drug delivery and site specific targeted delivery. Int. J. Pharmaceutic 457:124–35
- Nornoo AO, Osborne DW, Chow DS. (2008). Cremophor-free intervenous microemulsions for paclitaxel: formulation, cytotoxicity and hemolysis. Int J Pharm 349:108–16
- Qu G, Yao Z, Zhang C, et al. (2009). PEG conjugated N-octyl-O-sulfate chitosan micelles for delivery of paclitaxel: in vitro characterization and in vivo evaluation. Eur J Pharmaceutic Sci 37:98–105
- Qu D, Lin H, Zhang N, et al. (2013). In vitro evaluation on novel modified chitosan for targeted antitumor drug delivery. Carbohydr Polym 92:545–54
- Soenpenberg O, Sparreboon A, Dejongy MJA, et al. (2004). Real-time pharmacokinetics guiding clinical decisions:phase Ι study of a weekly scheduleof liposome encapsulated paclitaxel in patients with solid tumours. Eur J Cancer 40:681–8
- Tao Y, Xu J, Chen M, et al. (2012). Core cross-linked hyaluronan-styrylpyridinium micelles as a novel carrier for paclitaxel. Carbohyd Polym 88:118–24
- Wang F, Chen Y, Zhang D, et al. (2012). Folate-mediated targeted and intracellular delivery of paclitaxel using a novel deoxycholic acid-O-carboxymethylated chitosan-folic acid micelles. Int J Nanomed 7:325–37
- Wang F, Shen Y, Xu X, et al. (2013). Selective tissue distribution and long circulation endowed by paclitaxel loaded PEGylated poly(ε-caprolactone-co-l-lactide) micelles leading to improved anti-tumor effects and low systematic toxicity. Int J Pharm 456:101–12
- Xin HL, Chen LC, Gu JJ, et al. (2010). Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ε-caprolactone) nanoparticles: in vitro and in vivo evaluation. Int J Pharm 402:238–7
- Yang C, Attia A, Tan PK, et al. (2012). The role of non-covalent interactions in anticancer drug loading and kinetic stability of polymeric micelles. Biomaterials 33:2971–9
- Yuan H, Miao J, Du YZ, et al. (2008). Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells. Int J Pharm 348:137–45
- Zhang X, Jackson JK, Burt HM. (1996). Development of amphiphilic diblock copolymers as micellar carriers of taxol. Int J Pharm 132:195–206
- Zhang C, Qu G, Sun Y, et al. (2008). Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-o-sulfate chitosan micelles loaded with paclitaxel. Biomaterials 29:1233–41
- Zhang W, Shi Y, Chen Y, et al. (2011). Multifunctional Pluronic P123/F127 mixed polymeric micelles loaded with paclitaxel for the treatment of multidrug resistant tumors. Biomaterials 32:2894–906
- Zhu ZS, Li Y, Li XL, et al. (2010). Paclitaxel-loaded poly(N-vinylpyrrolidone)-b-poly(ε-caprolactone) nanoparticles: preparation and antitumor activity in vivo. J Control Release 142:438–46